13
Aug

San Diego’s Otonomy pulled off a $100 million Wall Street debut, lining its pockets as it works to get a late-stage ear treatment through the FDA and onto the market.

…read more

Source: Ear disease biotech Otonomy bags $100M in a booming IPO

    

0 No comments